Updating search results...

Search Resources

2 Results

View
Selected filters:
  • animal-models
Odoribacter laneus given orally improves glucose tolerance and inflammatory profiles in obese mice
Unrestricted Use
CC BY
Rating
0.0 stars

This resource is a video abstract of a research paper created by Research Square on behalf of its authors. It provides a synopsis that's easy to understand, and can be used to introduce the topics it covers to students, researchers, and the general public. The video's transcript is also provided in full, with a portion provided below for preview:

"Succinate is a metabolite and extracellular signal transductor with complex, but largely inflammatory, roles in the human body. Circulating succinate is elevated in patients with obesity and type 2 diabetes and has been linked to numerous complications. Both human cells and gut bacteria generate succinate, but how microbial succinate production impacts circulating levels and host health remains unclear. In a recent study, combined evidence from human patients and mice point to intestinal succinate as a key factor in obesity-related metabolic disturbances. Specifically, gut microbiota is identified as a relevant source of the high levels of circulating succinate found in obesity. However, modulation of intestinal flora dysbiosis of obese mice with succinate-consuming bacteria as a probiotic might reduce circulating succinate levels. Odoribacter laneus was a particularly promising candidate for this purpose. O..."

The rest of the transcript, along with a link to the research itself, is available on the resource itself.

Subject:
Biology
Life Science
Material Type:
Diagram/Illustration
Reading
Provider:
Research Square
Provider Set:
Video Bytes
Date Added:
04/14/2023
Two Years Later: Journals Are Not Yet Enforcing the ARRIVE Guidelines on Reporting Standards for Pre-Clinical Animal Studies
Unrestricted Use
CC BY
Rating
0.0 stars

A study by David Baker and colleagues reveals poor quality of reporting in pre-clinical animal research and a failure of journals to implement the ARRIVE guidelines. There is growing concern that poor experimental design and lack of transparent reporting contribute to the frequent failure of pre-clinical animal studies to translate into treatments for human disease. In 2010, the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines were introduced to help improve reporting standards. They were published in PLOS Biology and endorsed by funding agencies and publishers and their journals, including PLOS, Nature research journals, and other top-tier journals. Yet our analysis of papers published in PLOS and Nature journals indicates that there has been very little improvement in reporting standards since then. This suggests that authors, referees, and editors generally are ignoring guidelines, and the editorial endorsement is yet to be effectively implemented.

Subject:
Applied Science
Health, Medicine and Nursing
Life Science
Material Type:
Reading
Provider:
PLOS Biology
Author:
Ana Sottomayor
David Baker
Katie Lidster
Sandra Amor
Date Added:
08/07/2020